BEYOND INC (BYON)

US6903701018 - Common Stock

6.26  +0.56 (+9.82%)

After market: 6.34 +0.08 (+1.28%)

Fundamental Rating

1

Taking everything into account, BYON scores 1 out of 10 in our fundamental rating. BYON was compared to 119 industry peers in the Specialty Retail industry. BYON may be in some trouble as it scores bad on both profitability and health. BYON is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year BYON has reported negative net income.
In the past year BYON has reported a negative cash flow from operations.
In multiple years BYON reported negative net income over the last 5 years.
In multiple years BYON reported negative operating cash flow during the last 5 years.

1.2 Ratios

BYON has a Return On Assets of -79.03%. This is amonst the worse of the industry: BYON underperforms 94.87% of its industry peers.
BYON has a worse Return On Equity (-172.55%) than 81.20% of its industry peers.
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROIC N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 19.00%, BYON is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BYON has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for BYON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%

1

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYON has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BYON has been increased compared to 5 years ago.
The debt/assets ratio for BYON is higher compared to a year ago.

2.2 Solvency

BYON has an Altman-Z score of 0.32. This is a bad value and indicates that BYON is not financially healthy and even has some risk of bankruptcy.
BYON has a Altman-Z score of 0.32. This is amonst the worse of the industry: BYON underperforms 81.20% of its industry peers.
BYON has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
BYON has a Debt to Equity ratio of 0.17. This is in the better half of the industry: BYON outperforms 64.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC10.04%

2.3 Liquidity

A Current Ratio of 0.97 indicates that BYON may have some problems paying its short term obligations.
With a Current ratio value of 0.97, BYON is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
BYON has a Quick Ratio of 0.97. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
BYON has a Quick ratio of 0.91. This is in the better half of the industry: BYON outperforms 73.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.91

3

3. Growth

3.1 Past

BYON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -562.34%.
Looking at the last year, BYON shows a decrease in Revenue. The Revenue has decreased by -6.66% in the last year.
BYON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.04% yearly.
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.03%
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-16.58%

3.2 Future

Based on estimates for the next years, BYON will show a very strong growth in Earnings Per Share. The EPS will grow by 20.23% on average per year.
BYON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.03% yearly.
EPS Next Y-123.16%
EPS Next 2Y7.78%
EPS Next 3Y21.05%
EPS Next 5Y20.23%
Revenue Next Year-6.5%
Revenue Next 2Y-1.13%
Revenue Next 3Y3.38%
Revenue Next 5Y11.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BYON. In the last year negative earnings were reported.
Also next year BYON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BYON's earnings are expected to grow with 21.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.78%
EPS Next 3Y21.05%

0

5. Dividend

5.1 Amount

BYON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BEYOND INC

NYSE:BYON (1/6/2025, 8:22:57 PM)

After market: 6.34 +0.08 (+1.28%)

6.26

+0.56 (+9.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)02-18 2025-02-18/amc
Inst Owners67.4%
Inst Owner ChangeN/A
Ins Owners1.3%
Ins Owner Change31.02%
Market Cap288.27M
Analysts72.94
Price Target16.1 (157.19%)
Short Float %16.28%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.49%
Min EPS beat(2)-81.15%
Max EPS beat(2)-15.83%
EPS beat(4)0
Avg EPS beat(4)-60.49%
Min EPS beat(4)-81.63%
Max EPS beat(4)-15.83%
EPS beat(8)3
Avg EPS beat(8)-50.83%
EPS beat(12)6
Avg EPS beat(12)-33.8%
EPS beat(16)10
Avg EPS beat(16)30.38%
Revenue beat(2)1
Avg Revenue beat(2)-5.66%
Min Revenue beat(2)-13.51%
Max Revenue beat(2)2.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-13.51%
Max Revenue beat(4)8.93%
Revenue beat(8)4
Avg Revenue beat(8)-2.46%
Revenue beat(12)5
Avg Revenue beat(12)2.84%
Revenue beat(16)7
Avg Revenue beat(16)2.73%
PT rev (1m)0%
PT rev (3m)-24.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-29.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 1.47
P/tB 1.81
EV/EBITDA N/A
EPS(TTM)-5.1
EYN/A
EPS(NY)-1.63
Fwd EYN/A
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)-3.92
OCFYN/A
SpS32.06
BVpS4.26
TBVpS3.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.03%
ROE -172.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-6.55%
ROA(5y)-8.47%
ROE(3y)-14.74%
ROE(5y)-27.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5Y0.7%
F-Score2
Asset Turnover3.45
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 115.37%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.91
Altman-Z 0.32
F-Score2
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)131.23%
Cap/Depr(5y)105.16%
Cap/Sales(3y)1.38%
Cap/Sales(5y)1.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-562.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118.03%
EPS Next Y-123.16%
EPS Next 2Y7.78%
EPS Next 3Y21.05%
EPS Next 5Y20.23%
Revenue 1Y (TTM)-6.66%
Revenue growth 3Y-14.46%
Revenue growth 5Y-3.04%
Sales Q2Q%-16.58%
Revenue Next Year-6.5%
Revenue Next 2Y-1.13%
Revenue Next 3Y3.38%
Revenue Next 5Y11.03%
EBIT growth 1Y-278.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-47.84%
EBIT Next 3Y29.45%
EBIT Next 5Y22.53%
FCF growth 1Y-10803.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1263.8%
OCF growth 3YN/A
OCF growth 5YN/A